Alpha Lipoic Acid in Ulcerative Colitis

Recruiting now · Not applicable · Has a placebo group

Conditions studied: Ulcerative Colitis, Ulcerative Colitis (UC)

In brief

This study aims at evaluating the efficacy and safety of alpha-lipoic acid as adjuvant therapy to mesalamine in patients with mild to moderate ulcerative colitis due to its effect as anti-oxidant and anti-inflammatory drug which can help to improve disease.

Key facts

Study ID
NCT06067698
Run by
Tanta University
People needed
60
Starts
2023-10-01
Expected to finish
2025-04-01
Last updated by the study team
2025-02-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.